Medicines Vastly Overpriced, Generics Too: Discussion At WTO-WIPO-WHO Symposium 02/03/2018 by Catherine Saez, Intellectual Property Watch 1 Comment The price of hepatitis C medicine marked a turning point in the discussion on access to medicines, with developed countries suddenly confronted to prices they could not afford. This week, a symposium jointly organised by the World Health Organization, the World Trade Organization, and the World Intellectual Property Organization explored the question of the pricing of medicines. A number of suggestions were made to alleviate the issue, such as ensuring wide use of generic medicines, encouraging competition, and alerting countries about the cost of medicine production so they negotiate better with pharmaceutical companies.
Study: TRIPS Flexibilities Widely Used By Countries, Contrary To Reports 02/03/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment Despite the widespread view that the flexibilities included in international trade rules are not often used, a new study found that countries make extensive use of those flexibilities.
EU Commission Proposes Measures Against Illegal Online Content Including IP Infringement 01/03/2018 by William New, Intellectual Property Watch Leave a Comment The European Commission today recommended a set of operational measures against a wide range of online content considered illegal, lumping intellectual property rights-infringing material in with that of terrorists, child sexual abusers, hate speech, and commercial scams.
Video Gaming Industry Issues Attack On WHO’s Proposed Gaming Disorder Classification 01/03/2018 by Intellectual Property Watch Leave a Comment Teens’ (and others’) life-altering obsession with video gaming is well-known to almost any parent in most countries around the world, and the World Health Organization recently identified it as an addiction called “gaming disorder.” Today, the self-acclaimed $36 billion video gaming industry hit back with a statement about a new paper from “preeminent researchers and scientists” that it says casts doubt on the WHO’s efforts.
USPTO Rejects Use Of Tribal Sovereign Immunity In Allergan Patent Deal 01/03/2018 by Dugie Standeford for Intellectual Property Watch 1 Comment Native American tribes’ sovereign immunity can’t be used to avoid inter partes review (IPR) of patent validity, the US Patent and Trademark Office Patent and Appeal Board (PTAB) has ruled in a first-of-its-kind case.
WTO TRIPS Council Looks At IP And The Public Interest, Importance Of Research Exemption 28/02/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment A relatively new topic of discussion at the World Trade Organization committee on intellectual property is the relationship between intellectual property and the public interest. This week, WTO delegates discussed the application and benefits of a regulatory exception to IP rights allowing earlier entry of generics to the market, known as the Bolar exception. The committee also heard about a request from least-developed countries (LDCs) to improve technology transfer measures that developed countries have the obligation to provide under WTO rules.
Academies’ Group Urges EU Harmonisation Of Rules On Inventorship, Patenting 28/02/2018 by Intellectual Property Watch Leave a Comment A high-level group of academic experts in intellectual property rights and innovation in the European Union has released a statement highlighting the rise in inventions due to international research and development and says EU regulations on inventorship, assignment and patent filing should be assessed for harmonisation and reducing complexity.
WTO TRIPS Council: For Some, IP-Intensive Industries Are Engine Of Economy. For Others, IP Alone Is Not Sufficient 28/02/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment The World Trade Organization committee on intellectual property met this week and gave an opportunity to WTO members to discuss the value of intellectual property for micro, small and medium sized enterprises (MSMEs), and its importance for IP-intensive industries. Several members, such as the European Union on behalf of its members presented data to illustrate the importance of IP for MSMEs. Meanwhile, India and South Africa remarked that IP is only one factor to promote innovation, but are not a sufficient ingredient.
Section 1201 Rulemaking – The Process Is Moving Along 28/02/2018 by Intellectual Property Watch Leave a Comment Dave Davis writes: Section 1201 is a curious little section of the US Copyright Act, added by the Digital Millennium Copyright Act (DMCA) of 1998. But the matter covered in that section is of great importance in our digital age and, due to its triennial rulemaking requirement, ‘1201’ exceptions are a topic of considerable discussion every few years. As it turns out, 2018 is one of those years.
Authors’ Group Study: Copyright Safe Harbour Provisions Distort Market 28/02/2018 by Intellectual Property Watch 1 Comment Copyright “safe harbour” rules aimed at ensuring the free flow of information by internet service providers without liability for infringing content are “distorting the digital market, profiting tech giants and leading to significant underpayment of copyright owners,” according to an international authors’ industry association study released this week.